Close Menu

NEW YORK – Agios Pharmaceuticals said on Monday that it has partnered with PerkinElmer Genomics on a genetic testing program for patients with suspected hereditary anemias.

Testing will be performed using a next-generation sequencing-based panel comprising more than 50 genes and disorders known to cause hereditary anemias, such as pyruvate kinase deficiency.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.